Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Computed Tomography | Research

Quantitative CT parameters combined with preoperative systemic inflammatory markers for differentiating risk subgroups of thymic epithelial tumors

Authors: Rongji Gao, Jian Zhou, Juan Zhang, Jianzhong Zhu, Tiantian Wang, Chengxin Yan

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Thymic epithelial tumors (TETs) are the most common primary neoplasms of the anterior mediastinum. Different risk subgroups of TETs have different prognosis and therapeutic strategies, therefore, preoperative identification of different risk subgroups is of high clinical significance. This study aims to explore the diagnostic efficiency of quantitative computed tomography (CT) parameters combined with preoperative systemic inflammatory markers in differentiating low-risk thymic epithelial tumors (LTETs) from high-risk thymic epithelial tumors (HTETs).

Methods

74 Asian patients with TETs confirmed by biopsy or postoperative pathology between January 2013 and October 2022 were collected retrospectively and divided into two risk subgroups: LTET group (type A, AB and B1 thymomas) and HTET group (type B2, B3 thymomas and thymic carcinoma). Statistical analysis were performed between the two groups in terms of quantitative CT parameters and preoperative systemic inflammatory markers. Multivariate logistic regression analysis was used to determine the independent predictors of risk subgroups of TETs. The area under curve (AUC) and optimal cut-off values were calculated by receiver operating characteristic (ROC) curves.

Results

47 TETs were in LTET group, while 27 TETs were in HTET group. In addition to tumor size and CT value of the tumor on plain scan, there were statistical significance comparing in CT value of the tumor on arterial phase (CTv-AP) and venous phase (CTv-VP), and maximum enhanced CT value (CEmax) of the tumor between the two groups (for all, P < 0.05). For systemic inflammatory markers, HTET group was significantly higher than LTET group (for all, P < 0.05), including platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII). Multivariate logistic regression analysis showed that NLR (odds ratio [OR] = 2.511, 95% confidence interval [CI]: 1.322–4.772, P = 0.005), CTv-AP (OR = 0.939, 95%CI: 0.888–0.994, P = 0.031) and CTv-VP (OR = 0.923, 95%CI: 0.871–0.979, P = 0.008) were the independent predictors of risk subgroups of TETs. The AUC value of 0.887 for the combined model was significantly higher than NLR (0.698), CTv-AP (0.800) or CTv-VP (0.811) alone. The optimal cut-off values for NLR, CTv-AP and CTv-VP were 2.523, 63.44 Hounsfeld Unit (HU) and 88.29HU, respectively.

Conclusions

Quantitative CT parameters and preoperative systemic inflammatory markers can differentiate LTETs from HTETs, and the combined model has the potential to improve diagnostic efficiency and to help the patient management.
Literature
1.
go back to reference Carter BW, Tomiyama N, Bhora FY, Rosado de Christenson ML, Nakajima J, Boiselle PM, Detterbeck FC, Marom EM. A modern definition of mediastinal compartments. J Thorac Oncol. 2014;9:97–101.CrossRef Carter BW, Tomiyama N, Bhora FY, Rosado de Christenson ML, Nakajima J, Boiselle PM, Detterbeck FC, Marom EM. A modern definition of mediastinal compartments. J Thorac Oncol. 2014;9:97–101.CrossRef
2.
go back to reference Wang G, Du L, Lu X, Liu J, Zhang M, Pan Y, Meng X, Xu X, Guan Z, Yang J. Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas. BMC Cancer. 2022;22:895.CrossRefPubMedPubMedCentral Wang G, Du L, Lu X, Liu J, Zhang M, Pan Y, Meng X, Xu X, Guan Z, Yang J. Multiparameter diagnostic model based on 18F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomas. BMC Cancer. 2022;22:895.CrossRefPubMedPubMedCentral
3.
go back to reference Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:260–5.CrossRef Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5:260–5.CrossRef
4.
go back to reference Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, et al. The 2015 World Health Organization classification of tumors of the Thymus: continuity and changes. J Thorac Oncol. 2015;10:1383–95.CrossRefPubMedPubMedCentral Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, et al. The 2015 World Health Organization classification of tumors of the Thymus: continuity and changes. J Thorac Oncol. 2015;10:1383–95.CrossRefPubMedPubMedCentral
5.
go back to reference Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Lewis JE, Cassivi SD, Marks RS, Garces YI, Aubry MC. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis. AM J Surg Pathol. 2015;39:427–41.CrossRefPubMed Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Lewis JE, Cassivi SD, Marks RS, Garces YI, Aubry MC. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis. AM J Surg Pathol. 2015;39:427–41.CrossRefPubMed
6.
go back to reference Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420–9.CrossRefPubMed Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420–9.CrossRefPubMed
7.
go back to reference Tamburini N, Maniscalco P, Migliorelli A, Nigim F, Quarantotto F, Maietti E, Cavallesco G. Thymic epithelial tumors: prognostic significance and relationship between histology and the New TNM staging system. Thorac Cardiovasc Surg. 2020;68:433–9.CrossRefPubMed Tamburini N, Maniscalco P, Migliorelli A, Nigim F, Quarantotto F, Maietti E, Cavallesco G. Thymic epithelial tumors: prognostic significance and relationship between histology and the New TNM staging system. Thorac Cardiovasc Surg. 2020;68:433–9.CrossRefPubMed
8.
go back to reference Rioja P, Ruiz R, Galvez-Nino M, Lozano S, Valdiviezo N, Olivera M, Cabero O, Guillen ME, De La Guerra A, Amorin E, Barrionuevo C, Mas L. Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution. Thorac cancer. 2021;12:420–5.CrossRefPubMed Rioja P, Ruiz R, Galvez-Nino M, Lozano S, Valdiviezo N, Olivera M, Cabero O, Guillen ME, De La Guerra A, Amorin E, Barrionuevo C, Mas L. Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution. Thorac cancer. 2021;12:420–5.CrossRefPubMed
9.
go back to reference Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol. 2004;183:283–9.CrossRefPubMed Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol. 2004;183:283–9.CrossRefPubMed
10.
go back to reference Yasaka K, Akai H, Nojima M, Shinozaki-Ushiku A, Fukayama M, Nakajima J, Ohtomo K, Kiryu S. Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol. 2017;92:84–92.CrossRefPubMed Yasaka K, Akai H, Nojima M, Shinozaki-Ushiku A, Fukayama M, Nakajima J, Ohtomo K, Kiryu S. Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors. Eur J Radiol. 2017;92:84–92.CrossRefPubMed
11.
go back to reference Galli G, Trama A, Abate-Daga L, Brambilla M, Garassino MC, Fabbri A. Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an italian reference Center. Lung Cancer. 2020;146:66–9.CrossRefPubMed Galli G, Trama A, Abate-Daga L, Brambilla M, Garassino MC, Fabbri A. Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an italian reference Center. Lung Cancer. 2020;146:66–9.CrossRefPubMed
12.
go back to reference Yu C, Li T, Yang X, Zhang R, Xin L, Zhao Z, Cui J. Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors. BMC Med Imaging. 2022;22:37.CrossRefPubMedPubMedCentral Yu C, Li T, Yang X, Zhang R, Xin L, Zhao Z, Cui J. Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors. BMC Med Imaging. 2022;22:37.CrossRefPubMedPubMedCentral
13.
go back to reference Hu YC, Wu L, Yan LF, Wang W, Wang SM, Chen BY, Li GF, Zhang B, Cui GB. Predicting subtypes of thymic epithelial tumors using CT: new perspective based on a comprehensive analysis of 216 patients. Sci Rep. 2014;4:6984.CrossRefPubMedPubMedCentral Hu YC, Wu L, Yan LF, Wang W, Wang SM, Chen BY, Li GF, Zhang B, Cui GB. Predicting subtypes of thymic epithelial tumors using CT: new perspective based on a comprehensive analysis of 216 patients. Sci Rep. 2014;4:6984.CrossRefPubMedPubMedCentral
14.
go back to reference Alkaaki A, Abo Al-Saud A, Di Lena É, Ramirez-GarciaLuna JL, Najmeh S, Spicer J, Ferri L, Mulder D, Sirois C, Cools-Lartigue J. Factors predicting recurrence in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2022;62:ezac274. Alkaaki A, Abo Al-Saud A, Di Lena É, Ramirez-GarciaLuna JL, Najmeh S, Spicer J, Ferri L, Mulder D, Sirois C, Cools-Lartigue J. Factors predicting recurrence in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2022;62:ezac274.
15.
go back to reference Girard N. Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther. 2012;12:685–95.CrossRefPubMed Girard N. Chemotherapy and targeted agents for thymic malignancies. Expert Rev Anticancer Ther. 2012;12:685–95.CrossRefPubMed
16.
go back to reference Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v40–55.CrossRefPubMed Girard N, Ruffini E, Marx A, Faivre-Finn C, Peters S. Thymic epithelial tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v40–55.CrossRefPubMed
17.
go back to reference Gentili F, Monteleone I, Mazzei FG, Luzzi L, Del Roscio D, Guerrini S, Volterrani L, Mazzei MA. Advancement in diagnostic imaging of thymic tumors. Cancers. 2021;13:3599. Gentili F, Monteleone I, Mazzei FG, Luzzi L, Del Roscio D, Guerrini S, Volterrani L, Mazzei MA. Advancement in diagnostic imaging of thymic tumors. Cancers. 2021;13:3599.
18.
go back to reference Zhao Y, Chen H, Shi J, Fan L, Hu D, Zhao H. The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma. Eur J Cardiothorac Surg. 2015;48:698–704.CrossRefPubMed Zhao Y, Chen H, Shi J, Fan L, Hu D, Zhao H. The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma. Eur J Cardiothorac Surg. 2015;48:698–704.CrossRefPubMed
19.
go back to reference Yamazaki M, Oyanagi K, Umezu H, Yagi T, Ishikawa H, Yoshimura N, Aoyama H. Quantitative 3D shape analysis of CT images of Thymoma: a comparison with histological types. AJR Am J Roentgenol. 2020;214:341–7.CrossRefPubMed Yamazaki M, Oyanagi K, Umezu H, Yagi T, Ishikawa H, Yoshimura N, Aoyama H. Quantitative 3D shape analysis of CT images of Thymoma: a comparison with histological types. AJR Am J Roentgenol. 2020;214:341–7.CrossRefPubMed
20.
go back to reference Qu YJ, Liu GB, Shi HS, Liao MY, Yang GF, Tian ZX. Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage. Acad Radiol. 2013;20:66–72.CrossRefPubMed Qu YJ, Liu GB, Shi HS, Liao MY, Yang GF, Tian ZX. Preoperative CT findings of thymoma are correlated with postoperative Masaoka clinical stage. Acad Radiol. 2013;20:66–72.CrossRefPubMed
22.
go back to reference Wu SD, Ma YS, Fang Y, Liu LL, Fu D, Shen XZ. Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev. 2012;38:218–25.CrossRefPubMed Wu SD, Ma YS, Fang Y, Liu LL, Fu D, Shen XZ. Role of the microenvironment in hepatocellular carcinoma development and progression. Cancer Treat Rev. 2012;38:218–25.CrossRefPubMed
23.
go back to reference Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.CrossRefPubMed Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493–503.CrossRefPubMed
24.
25.
26.
go back to reference Guo L, Wang Q, Chen K, Liu HP, Chen X. Prognostic value of combination of inflammatory and tumor markers in Resectable Gastric Cancer. J Gastrointest Surg. 2021;25:2470–83.CrossRefPubMed Guo L, Wang Q, Chen K, Liu HP, Chen X. Prognostic value of combination of inflammatory and tumor markers in Resectable Gastric Cancer. J Gastrointest Surg. 2021;25:2470–83.CrossRefPubMed
27.
go back to reference Gu Y, Zheng F, Zhang Y, Qiao S. Novel Nomogram based on inflammatory markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma. Cancer Manag Res. 2022;14:895–907.CrossRefPubMedPubMedCentral Gu Y, Zheng F, Zhang Y, Qiao S. Novel Nomogram based on inflammatory markers for the Preoperative Prediction of Microvascular Invasion in Solitary Primary Hepatocellular Carcinoma. Cancer Manag Res. 2022;14:895–907.CrossRefPubMedPubMedCentral
28.
go back to reference Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143:2077–86.CrossRefPubMed Wang L, Wang C, Wang J, Huang X, Cheng Y. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2017;143:2077–86.CrossRefPubMed
29.
go back to reference Feng XL, Lei XB, Dong WT, Yan LF, Xin YK, Li GF, Jing Y, Duan SJ, Zhang J, Hu YC, Li B, Zhao SS, et al. Incidence and clinical variable inter-relationships of thymic epithelial tumors in northwest China. J Thorac Dis. 2018;10:6794–802.CrossRefPubMedPubMedCentral Feng XL, Lei XB, Dong WT, Yan LF, Xin YK, Li GF, Jing Y, Duan SJ, Zhang J, Hu YC, Li B, Zhao SS, et al. Incidence and clinical variable inter-relationships of thymic epithelial tumors in northwest China. J Thorac Dis. 2018;10:6794–802.CrossRefPubMedPubMedCentral
30.
go back to reference Choe J, Lee SM, Lim S, Choi SH, Kim N, Do KH, Seo JB. Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol. 2017;27:4030–6.CrossRefPubMed Choe J, Lee SM, Lim S, Choi SH, Kim N, Do KH, Seo JB. Doubling time of thymic epithelial tumours on CT: correlation with histological subtype. Eur Radiol. 2017;27:4030–6.CrossRefPubMed
31.
go back to reference Sadohara J, Fujimoto K, Müller NL, Kato S, Takamori S, Ohkuma K, Terasaki H, Hayabuchi N. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol. 2006;60:70–9.CrossRefPubMed Sadohara J, Fujimoto K, Müller NL, Kato S, Takamori S, Ohkuma K, Terasaki H, Hayabuchi N. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol. 2006;60:70–9.CrossRefPubMed
32.
go back to reference Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, Hamada S, Okumura M, Ohta M, Eimoto T, Miyagawa M, Müller NL, et al. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol. 2002;179:881–6.CrossRefPubMed Tomiyama N, Johkoh T, Mihara N, Honda O, Kozuka T, Koyama M, Hamada S, Okumura M, Ohta M, Eimoto T, Miyagawa M, Müller NL, et al. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol. 2002;179:881–6.CrossRefPubMed
33.
go back to reference Pan CC, Chen WY, Chiang H. Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Pathol. 2001;25:111–20.CrossRefPubMed Pan CC, Chen WY, Chiang H. Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Pathol. 2001;25:111–20.CrossRefPubMed
34.
go back to reference Hosseini S, Mofrad AME, Mokarian P, Nourigheimasi S, Azarhomayoun A, Khanzadeh S, Habibzadeh S, Ghaedi A. Neutrophil to lymphocyte ratio in Epilepsy: a systematic review. Mediators Inflamm. 2022;2022:4973996.CrossRefPubMedPubMedCentral Hosseini S, Mofrad AME, Mokarian P, Nourigheimasi S, Azarhomayoun A, Khanzadeh S, Habibzadeh S, Ghaedi A. Neutrophil to lymphocyte ratio in Epilepsy: a systematic review. Mediators Inflamm. 2022;2022:4973996.CrossRefPubMedPubMedCentral
35.
go back to reference Li L, Zhang H, Feng GL. Neutrophil-to-lymphocyte ratio predicts in-hospital mortality in Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2022;31:106611.CrossRefPubMed Li L, Zhang H, Feng GL. Neutrophil-to-lymphocyte ratio predicts in-hospital mortality in Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2022;31:106611.CrossRefPubMed
36.
go back to reference Su M, Ouyang X, Song Y. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis. J Affect Disord. 2022;308:375–83.CrossRefPubMed Su M, Ouyang X, Song Y. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and monocyte to lymphocyte ratio in depression: a meta-analysis. J Affect Disord. 2022;308:375–83.CrossRefPubMed
37.
go back to reference Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X, Han R, Jing X. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Ann Med. 2022;54:302–9.CrossRefPubMedPubMedCentral Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X, Han R, Jing X. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Ann Med. 2022;54:302–9.CrossRefPubMedPubMedCentral
38.
go back to reference Zhu X, Zhou J, Zhu Y, Yan F, Han X, Tan Y, Li R. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia. Australas Psychiatry. 2022;30:95–9.CrossRefPubMed Zhu X, Zhou J, Zhu Y, Yan F, Han X, Tan Y, Li R. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia. Australas Psychiatry. 2022;30:95–9.CrossRefPubMed
39.
go back to reference Ouyang H, Wang Z. Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children. Front Public Health. 2022;10:879523.CrossRefPubMedPubMedCentral Ouyang H, Wang Z. Predictive value of the systemic immune-inflammation index for cancer-specific survival of osteosarcoma in children. Front Public Health. 2022;10:879523.CrossRefPubMedPubMedCentral
40.
go back to reference Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15:221.CrossRefPubMedPubMedCentral Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. J Transl Med. 2017;15:221.CrossRefPubMedPubMedCentral
41.
go back to reference Li P, Li H, Ding S, Zhou J, NLR. PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Transl Res. 2022;14:3017–27.PubMedPubMedCentral Li P, Li H, Ding S, Zhou J, NLR. PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma. Am J Transl Res. 2022;14:3017–27.PubMedPubMedCentral
42.
go back to reference Wang L, Ruan M, Yan H, Lei B, Sun X, Chang C, Liu L, Xie W. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Cytokine. 2020;133:155149.CrossRefPubMed Wang L, Ruan M, Yan H, Lei B, Sun X, Chang C, Liu L, Xie W. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors. Cytokine. 2020;133:155149.CrossRefPubMed
Metadata
Title
Quantitative CT parameters combined with preoperative systemic inflammatory markers for differentiating risk subgroups of thymic epithelial tumors
Authors
Rongji Gao
Jian Zhou
Juan Zhang
Jianzhong Zhu
Tiantian Wang
Chengxin Yan
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11332-0

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine